Apoptosis, Proliferation, and Expression of Bcl-2, Fas, and Fas Ligand in Bronchial Biopsies from Asthmatics
- 1 November 1998
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 19 (5) , 747-757
Abstract
The in situ apoptosis and the expression of molecules involved in this process, such as Bcl-2, Fas, and its ligand, Fas ligand (FasL), were examined in bronchial biopsies from healthy control subjects and from steroid-untreated or -treated asthmatics, using terminal transferase-mediated deoxyuridyltriphosphate nick-end labeling and immunohistochemical techniques, respectively. Bronchial submucosa from steroid- untreated asthmatics showed an increase in the number of eosinophils and a decrease in that of apoptotic cells compared with that of control subjects, but no significant changes in the number of T lymphocytes or in that of cells expressing Bcl-2, Fas, or FasL. Treatment with steroids reduced airway eosinophilia and augmented the proportion of apoptotic eosinophils. Compared with control subjects or untreated patients, steroid-treated asthmatics exhibited increased expression of Bcl-2, Fas, FasL, and of proliferating cell nuclear antigen (PCNA) in their bronchial epithelium, without changes in the number of apoptotic cells. Moreover, the intensity of the expression of Bcl-2, Fas, and FasL correlates well with that of PCNA. We conclude that steroids may reduce the inflammatory cell infiltrate in the bronchial submucosa in part by promoting eosinophil apoptosis and by inducing the expression of FasL on bronchial epithelial cells. Treatment with steroids may also augment survival and proliferation of epithelial cells, possibly via the expression of Bcl-2 and PCNA.Keywords
This publication has 41 references indexed in Scilit:
- Repair mechanisms in asthmaJournal of Allergy and Clinical Immunology, 1996
- The role of apoptosis in the pathogenesis and treatment of diseasesEuropean Respiratory Journal, 1996
- Apoptosis and inflammationMediators of Inflammation, 1995
- Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part I)European Respiratory Journal, 1994
- A family of ligands for the TNF receptor superfamilyStem Cells, 1994
- Bcl-2 and the regulation of programmed cell deathJournal of Cell Biology, 1994
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- Aerosol Steroids as Primary Treatment of Mild AsthmaNew England Journal of Medicine, 1991
- Cellular Events in the Bronchi in Mild Asthma and after Bronchial ProvocationAmerican Review of Respiratory Disease, 1989
- Eosinophils and Mast Cells in Bronchoalveolar Lavage in Subjects with Mild Asthma: Relationship to Bronchial HyperreactivityAmerican Review of Respiratory Disease, 1988